TwoStep Therapeutics, Inc. is a biotechnology company developing a tumor-targeting platform built around a polyspecific integrin-binding peptide ("PIP") designed to deliver diverse payloads for solid tumors. Led by CEO and Co-Founder Tlyn Miller, the company focuses on expanding the reach of targeted cancer therapies.
Subscribe to see TwoStep Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
TwoStep Therapeutics, Inc. is a biotech company headquartered in United States. It has raised at least $27.6M across the 2 funding rounds on record. Its most recent funding round raised $21.1M in January 2026. Xcout tracks 13 named people at TwoStep Therapeutics, Inc., including Caitlyn Miller (Chief Executive Officer). Xcout recorded 1 job posting from TwoStep Therapeutics, Inc. in the last 90 days.
7 more named people on record for TwoStep Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
At least $27.6M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $21.1M | — | |
| SEC Form D filing | $6.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 1 job posting from TwoStep Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see TwoStep Therapeutics, Inc.'s hiring signals →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.